NCT03223909View on ClinicalTrials.gov

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)

PHASE4CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

October 16, 2018

Study Completion Date

December 16, 2018

Conditions
Dry Eye Syndrome
Interventions
DRUG

PRO-087

0.1% sodium hyaluronate, free-preservative 0.18% chondroitin sulphate

DRUG

Systane Ultra

Is a sterile solution containing polyethylene glycol 400, propylene glycol, hydroxypropyl-guar, sorbitol, aminomethylpropanol, boric acid, potassium chloride, sodium chloride and POLYQUAD® (poly-hydronium chloride) 0.001% as preservative.

DRUG

Systane Ultra Preservative Free

Polyethylene Glycol 400 0.4%Lubricant, Propylene Glycol 0.3% Lubricant,

Trial Locations (1)

36670

Fernando Rodriguez Sixtos Higuera, Irapuato

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT03223909 - Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) | Biotech Hunter | Biotech Hunter